金凯生科2025年净利同比预增138.28%至200.45%

Core Viewpoint - Jinkai Biotechnology (301509) forecasts a significant increase in net profit for 2025, projecting a range of approximately 92 million to 116 million yuan, representing a year-on-year growth of 138.28% to 200.45% [1] Group 1 - The increase in net profit is attributed to a recovery in end-user demand and the delivery schedule of customer orders, leading to an increase in delivered orders during the reporting period [1] - The overall gross profit margin has improved due to the impact of the product mix of delivered orders [1] - These combined factors are expected to result in a substantial year-on-year increase in the company's performance for 2025 [1]